Stock Report

Download full stock data and analysis for free Last Updated: 09-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Yumanity Therapeutics (YMTX) Key Ratios

Stock Card factsheet share-fund-plan-icon

$1.89

up-down-arrow $0.15 (8.62%)

As on 16-Dec-2022 16:00EDT

Market cap

info icon

$21 Mln

Revenue (TTM)

info icon

$5 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

3.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -15.39 -14.25 -65.83 -- --
EBIT 30.55 64.64 62.71 -26.82 --
Net Profit 30.59 66.22 63.04 -- --
EPS 30.64 -124.45 -148.48 -- --
Book Value -- -- 189.47 -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-21Dec-20
EBIT-Margin info -636.82---640.34-467.57-806.08
Net Margin info -----660.61----
Return on equity info 85.65---372.55-99.12322.12
Return on Capital info 381.47-----67.061,130.19
Return on Assets info -110.65---63.14-50.68-103.99
Debt to Equity (x) info ----0.001.180.19

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
--
-67.06
1,130.19
81.28
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-372.55

Lower than Peers by 350.54

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
-372.55
-99.12
322.12
33.96
--
Peer Median
-22.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-63.14

Lower than Peers by 50.59

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
-63.14
-50.68
-103.99
-177.26
--
Peer Median
-12.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-640.34

Lower than Peers by 590.11

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
-640.34
-467.57
-806.08
--
--
Peer Median
-50.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-660.61

Lower than Peers by 603.83

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
-660.61
-491.09
-833.63
--
--
Peer Median
-56.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-65.83

Lower than Peers by 81.93

Year on year growth in net sales

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
-65.83
0.17
--
--
--
Peer Median
16.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

62.71

Higher than Peers by 50.03

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
62.71
32.34
-85.29
-28.27
--
Peer Median
12.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

63.04

Higher than Peers by 54.65

Year on year growth in profit after tax

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
63.04
31.28
-84.20
--
--
Peer Median
8.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-148.48

Lower than Peers by 179.72

Year on year growth in earnings per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
-148.48
-3.76
--
--
--
Peer Median
31.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

12.07

Higher than Peers by 9.93

Year on year growth in book value per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
12.07
--
--
--
--
Peer Median
2.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
--
1.18
0.19
-0.16
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.04

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
0.04
0.46
0.13
-0.01
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.21

Lower than Peers by 1.51

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
2.21
1.88
2.84
3.26
7.39
Peer Median
3.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.21

Lower than Peers by 1.46

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
2.21
--
--
--
--
Peer Median
3.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-31.59

Lower than Peers by 31.25

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
-31.59
-19.88
-29.26
-24.81
--
Peer Median
-0.34
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
--
62.16
--
--
--
Peer Median
23.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.10

Lower than Peers by 0.16

Sales / Average Total Assets

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
0.10
0.10
0.12
--
--
Peer Median
0.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
--
227.03
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
--
-0.02
-0.43
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

3.33

Lower than Peers by 1.57

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
3.33
0.03
0.44
--
--
Peer Median
4.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-0.32

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
-0.32
0.22
0.91
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

21

Lower than Peers by 70

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Yumanity Therapeutics (YMTX)
21
--
--
--
--
Peer Median
91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...